Marsha Simon, Ph.D, President of Simon&Co. , comments on the reactions to the Trump Administration’s proposed Medicare Part B Drug Pricing Plan. October 30, 2018 Read moreMarsha Simon, Ph.D, President of Simon&Co. , comments on the reactions to the Trump Administration’s proposed Medicare Part B Drug Pricing Plan.
Marsha Simon, PhD, president of Simon & Co Quoted in MedPage Today Story on GAO Report on 340B Contract Pharmacies July 6, 2018 Read moreMarsha Simon, PhD, president of Simon & Co Quoted in MedPage Today Story on GAO Report on 340B Contract Pharmacies
New CMS Policy on Mandatory 340B Carve0Out June 4, 2018 Read moreNew CMS Policy on Mandatory 340B Carve0Out
Senate HELP Hearing Probes Original Purpose of 340B Drug Discount Program April 4, 2018 Read moreSenate HELP Hearing Probes Original Purpose of 340B Drug Discount Program
Medicaid: Covered Outpatient Drugs Final Rule (CMS-2345-FC) Summary of Major Provisions January 29, 2016 Read moreMedicaid: Covered Outpatient Drugs Final Rule (CMS-2345-FC) Summary of Major Provisions
President Marsha Simon Authors Article on 340B Program September 4, 2014 Read morePresident Marsha Simon Authors Article on 340B Program
